The rising cost of health care, caused by a combination of aging population and rapidly increasing fundamental understanding of biological and pathological processes supporting care and cure, demands the fast introduction of evidence-based technological support for the medical professionals. Artificial intelligence is without doubt one of the most promising enabling technologies to offer this support. We will present three very different use cases where artificial intelligence, or more correctly machine learning, proves to make a big difference: for cheaper discovery of new drugs, for earlier diagnosis of metastatic cancers and for more accurate prediction of premature birth.


Rudy Lauwereins

Vice-President @ imec / Professor @ KULeuven